1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
申请人:Cubist Pharmaceuticals, Inc.
公开号:US08916709B2
公开(公告)日:2014-12-23
β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.